Another study found that fingolimod (FTY720), a sphingosine analog, in combination with sorafenib, exhibited significant cytotoxic effects on EGFR wild-type A549 NSCLC cells [37]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.